Home › Funds › NYLIM VP FUNDS TRUST › NYLIM VP Balanced Portfolio
Fund family: NYLIM VP FUNDS TRUST · Filed by NYLIM VP FUNDS TRUST (CIK 887340) · SEC series S000009437
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 779 with, 29 against, 0 abstentions (not counted as with management); 1 items carried no recommendation. Shareholder proposals: 6 FOR, 23 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as NYLIM VP FUNDS TRUST’s manager page (23,978 ballot items across 29 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | NYLIM VP FUNDS TRUST | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 98.4% | 743 | 95.1% | 20,920 |
| Backed environmental and social shareholder proposals at US companies | n/a | 16 | 7.3% | 669 |
Each ballot item this fund voted is set against the votes of the other NYLIM VP FUNDS TRUST funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most NYLIM VP FUNDS TRUST funds on 7 items (2.6% of the 265 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most NYLIM VP FUNDS TRUST funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Pfizer Inc. | 2026-04-23 | Shareholder Adopt an Independent Chair Policy | For | AGAINST — 4 of 4 NYLIM VP FUNDS TRUST funds | Against | Not approved, 28.8% support |
| The Progressive Corporation | 2026-05-08 | Election of Directors: Lawton W. Fitt | Against | FOR — 4 of 4 NYLIM VP FUNDS TRUST funds | Against | Elected, 85.8% support |
| NetApp, Inc. | 2025-09-10 | To approve an amendment to NetApp's 2021 Equity Incentive Plan. | For | AGAINST — 4 of 4 NYLIM VP FUNDS TRUST funds | For | Approved, 68.0% support |
| Broadcom Inc. | 2026-04-20 | Advisory vote to approve the named executive officer compensation. | For | AGAINST — 5 of 8 NYLIM VP FUNDS TRUST funds | For | Approved, 66.4% support |
| KKR & Co. Inc. | 2026-05-21 | An amendment to the Existing Charter to establish stockholders' meetings as the sole mechanism for approval of matters on which holders of common stock are required or permitted to vote. | For | AGAINST — 3 of 4 NYLIM VP FUNDS TRUST funds | For | — |
| Zoetis Inc. | 2026-05-20 | Shareholder Shareholder proposal to permit shareholder action by written consent. | For | AGAINST — 3 of 5 NYLIM VP FUNDS TRUST funds | Against | — |
| Chubb Limited | 2026-05-21 | Election of the Board of Directors: David H. Sidwell | For | AGAINST — 2 of 3 NYLIM VP FUNDS TRUST funds | For | — |
Download all 7 differences (CSV)
The same votes as “with management” above, by the sector of the company voted on. 90.5% of this fund’s 808 such votes could be given a sector; the other 77 (9.5%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Finance | 223 | 6 | 2.7% |
| Health Care | 119 | 13 | 10.9% |
| Technology | 81 | 5 | 6.2% |
| Utilities | 70 | 1 | 1.4% |
| Industrials | 59 | 1 | 1.7% |
| Telecommunications | 39 | 1 | 2.6% |
| Consumer Discretionary | 37 | 1 | 2.7% |
| Consumer Staples | 29 | 1 | 3.4% |
| Energy | 27 | 0 | 0.0% |
| Real Estate | 21 | 0 | 0.0% |
| Basic Materials | 13 | 0 | 0.0% |
| Miscellaneous | 13 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 575 | 0 |
| Audit-related | 61 | 0 |
| Say-on-Pay | 56 | 0 |
| Corporate Governance | 33 | 7 |
| Capital Structure | 27 | 0 |
| Compensation | 27 | 1 |
| Shareholder Rights and Defenses | 14 | 5 |
| Other Social Issues | 8 | 6 |
| Diversity, Equity, and Inclusion | 4 | 4 |
| Environment or Climate | 4 | 4 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| JPMorgan Chase & Co. | May 19, 2026 | $9M | 17 | 4 |
| Johnson & Johnson | April 23, 2026 | $8M | 15 | 1 |
| Merck & Co., Inc. | May 26, 2026 | $6M | 18 | 3 |
| Cisco Systems, Inc. | December 16, 2025 | $6M | 13 | 1 |
| Marathon Petroleum Corporation | April 29, 2026 | $6M | 8 | 0 |
| UnitedHealth Group Incorporated | June 1, 2026 | $6M | 12 | 1 |
| Elevance Health, Inc. | May 13, 2026 | $5M | 6 | 1 |
| Pfizer Inc. | April 23, 2026 | $4M | 16 | 1 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| May 19, 2026 | JPMorgan Chase & Co. | Report on congruence of security, resiliency, and climate initiatives Shareholder proposal | Against | For |
| May 19, 2026 | JPMorgan Chase & Co. | Independent board chairman Shareholder proposal | Against | For |
| April 23, 2026 | Johnson & Johnson | Independent Board Chair Shareholder proposal | Against | For |
| May 26, 2026 | Merck & Co., Inc. | Shareholder proposal regarding a report on DEI risks in federal contracting. Shareholder proposal | Against | For |
| May 26, 2026 | Merck & Co., Inc. | Shareholder proposal regarding a report on healthcare coverage gaps. Shareholder proposal | Against | For |
| December 16, 2025 | Cisco Systems, Inc. | Stockholder Proposal - Approval to request the Board to conduct an evaluation and issue a report assessing how Cisco's Inclusion programs provide positive financial value to shareholders. Shareholder proposal | Against | For |
| June 1, 2026 | UnitedHealth Group Incorporated | If properly presented at the 2026 Annual Meeting of Shareholders, the shareholder proposal requesting the adoption of a policy to require any Board Chair to be independent. Shareholder proposal | Against | For |
| May 13, 2026 | Elevance Health, Inc. | Shareholder Proposal Requesting an Independent Study on the Impact of Prohibiting Corporate Contributions to Partisan 527 Tax-Exempt Political Groups. Shareholder proposal | Against | For |
| April 23, 2026 | Pfizer Inc. | Adopt an Independent Chair Policy Shareholder proposal | For | Against |
| September 10, 2025 | NetApp, Inc. | To approve a stockholder proposal regarding support for Special Shareholder Meeting Improvement. Shareholder proposal | Against | For |
| April 30, 2026 | Gilead Sciences, Inc. | To vote on a stockholder proposal requesting an independent Board Chair policy, if properly presented at the Annual Meeting. Shareholder proposal | Against | For |
| April 30, 2026 | Gilead Sciences, Inc. | To vote on a stockholder proposal requesting a report on the impact of extended patent exclusivities on patient access, if properly presented at the Annual Meeting. Shareholder proposal | Against | For |
812 ballot items at 62 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, NYLIM VP Balanced Portfolio voted at 62 shareholder meetings of 60 companies, on 812 ballot items in all. Where management made a recommendation, the fund followed it on 96.4% of the items and voted against it 29 times. Its most frequent area of disagreement was corporate governance (7 of its votes against management). It voted on 29 shareholder proposals. It voted FOR the board's own proposals more often than NYLIM VP FUNDS TRUST's funds as a whole (98.4% against 95.1%). It voted differently from most NYLIM VP FUNDS TRUST funds on 7 items.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of NYLIM VP FUNDS TRUST’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.